2014;129(25 Suppl 2):S102138
Your provider can monitor your response, adjust your dose when appropriate, and help manage side effects before they interrupt your progress
However, past pancreatitis is not a contraindication for these agents, and contrary to the previous warning, recent studies have not shown an increased pancreatic risk associated with GLP-1 RAs, leading to ongoing revisions in treatment guidelines
Among non-diabetic patients, only those prescribed semaglutide had a lower likelihood of anxiety compared to those not prescribed the GLP-1 medication, while those prescribed liraglutide had no statistically significant difference
Despite widespread demand, affordability and insurance coverage lag far behind medical efficacy